Immunotherapy, Tumor Microenvironment and Survival Signaling

• अन्य लेखक: Golubovskaya, Vita (संपादक)
• स्वरूप: इलेक्ट्रोनिक पुस्तक अध्याय
• भाषा: अंग्रेज़ी
• प्रकाशित: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• विषय: Medicine; Clinical & internal medicine; Autophagy; colorectal cancer; immunotherapy; tumor stroma; tumor microenvironment; immune checkpoint inhibitors; chemotherapy; tyrosine kinase inhibitors; angiogenesis; check point inhibitors; programmed cell death protein 1; programmed cell death 1 ligand 1; cardiotoxicity; lung metastasis; CAR-T; hypoxia; tumor; microenvironment; CD19; BCMA; cancer; melanoma; immune escape; antigen loss; chimeric antigen receptor; electroporation; lentivirus; lentiviral transduction; macrophages; leukemia cells; lytic peptides; targeted therapy; dendritic cells; pathogenesis; risk factors; breast cancer; resistance; checkpoint; targeted treatment; personalized medicine; pediatric solid tumors; chimeric antigen receptors; cancer vaccines; oncolytic viral therapy; immunomodulation; DCLK1; tumor stem cells; clonogenicity; mitochondria; mitochondrial transfer; tunneling nanotubes; triple-negative breast cancer; immune checkpoint inhibitor; combination therapy; cancer nanomedicine; tumor antigens; cancer metabolism; cancer immunotherapy; nanoparticles; immunotherapeutic agent; immunomodulators; tuft cells; cancer stem cells; immunotherapies; myeloid-derived suppressor cells; regulatory T cells; crosstalk; tumor immune evasion; cell-cell contact; β2 integrins; CD18; CD11; CAR-T cells; CD37; cell therapy; tumor antigen; lymphoma; CAR macrophage; CAR T cell; solid tumors; immunometabolism; miRNA; immunogenic cell death; n/a
• ऑनलाइन पहुंच: DOAB: download the publication; DOAB: description of the publication

The book is based on the Cancers journal Special Issue entitled "Immunotherapy, Tumor Microenvironment and Survival Signaling", and focuses on important problems concerning tumors and tumor microenvironment interactions, as well as novel immunotherapies such as CAR-T cell therapy. Immunoth...